Notice
To schedule your COVID vaccine appointment or for more resources visituwhealth.org/covid
To schedule your COVID vaccine appointment or for more resources visituwhealth.org/covid
Yaohui Gloria Xu, MD, PhD, earned her medical degree from the Sun Yat-sen University of Medical Sciences in China and completed her residency at the University of Chicago Hospitals.
Dr. Xu is a Board Certified dermatologist and Mohs micrographic surgery/procedural dermatology fellowship trained surgeon, specializing in Mohs micrographic surgery, with interests that span both cosmetic and general dermatology.
Dr. Xu has particular interest and expertise in dermatologic surgery and cutaneous oncology. In addition to managing non-melanoma skin cancers using well-established Mohs surgery, she also uses modified Mohs surgery to optimize the management of melanoma, particularly difficult cases of melanoma, such as lentigo maligna with ill-defined margins on the head and neck areas, amelanotic melanoma and recurrent melanoma. She has published many articles on surgical and general dermatology in peer-reviewed medical journals, she has written book chapters on dermatologic surgery and cutaneous oncology, and she has been an invited speaker at the national Mohs College Annual Meetings.
Dr. Xu is actively involved in several research projects related to melanoma and other skin cancers. Along with her co-PI, Dr. Vladimir S. Spiegelman, she is working on a project on cutaneous squamous cell carcinoma (SCC) in non-transplant and transplant patients. It is hoped that this research will lead to pre-operative treatment to reduce the size of the tumor or post-operative treatment to enhance the cure rate. She is involved in a project with [Dr. Mark Albertini](https://www.uwhealth.org/findadoctor/profile/mark-r-albertini-md/5373) to study immune responses to melanoma. She is also involved in a project led by Andrew Sheinis, UW Professor of Astronomy, to determine if an imaging technology developed for Astronomy can be used to detect early melanoma as well as to detect cancer margins prior to surgical removal.